Resources
Menu
Close
Resources
Contact us
Oral solid dose
Sterile injectables
Antibody-drug conjugates
Tech transfer
OSD manufacturing
SI manufacturing
ADC manufacturing
Careers
Leadership team
Sustainability
IP protection
Expert insights
Oral solid dose manufacturing services
Making the complex. Simple.
Keep your oral solid dose (OSD) program moving forward with an approach designed to minimize rework and delays, backed by a track record of >90% on-time, in-full (OTIF) delivery with no issues on audit.
With decades of experience, deep regulatory knowledge across 150+ countries, and state-of-the-art oral solid dose manufacturing facilities, we support your OSD program from late-stage clinical through to lifecycle management.
Our services span diverse delivery technologies and compound classifications, with advanced process analytical technology and integrated packaging capabilities that help simplify your supply chain without compromising the quality your patients deserve.
Speak to our OSD experts today
Dry granulation (roller compaction)
Wet and dry milling
Extrusion/spheronization
Compression
Encapsulation
Film coating
Sugar coating
Active coating
Solvent coating
Fluid bed coating
Branding and printing
Automated inspection
CMC preparation and submission support
Pre-approval inspection readiness
Cytostatics and cytotoxics
Immunosuppressants
Sensitizers
Hormones
Controlled substances
Multi-product
Steroids
Non-steroidal anti-inflammatories
Centers of Excellence for bottle and blister
Automated lines
High-volume and flexible-run packaging
Containment control (OEL 10,000–0.01 μg/m3)
Cold-forming and thermoforming
Serialization
Why choose Pfizer CentreOne for oral solid dose manufacturing?
Your complex OSD challenges, expertly handled.
With decades of experience in complex tablet and capsule production, including highly potent, hormone, and low-bioavailability drugs, we bring the scientific depth to help support your most demanding OSD programs.
Specialized technologies like laser drilling and modified-release manufacturing, housed within OEB 1–5 facilities, help turn that experience into consistent, high-quality results.
Built for reliability.
Designed for quality.
We engineer your project's journey to market, with streamlined scale-up and structured tech transfer designed to help reduce risk from day one.
Advanced process analytical technology helps cut costs and boost efficiency as your product moves through critical milestones, supported by supply chain practices designed to help safeguard reliable delivery to patients.
Flexibility in scale and scope.
From phase II clinical to commercial supply, our oral solid dose manufacturing process flexes to help meet your evolving needs.
Format, batch size, and packaging flexibility help support your program at every stage. And with real-time data sharing and transparent communication, you stay informed and aligned throughout.
Our global network of state-of-the-art facilities combines thousands of Pfizer experts with specialized manufacturing technologies and flexible packaging capabilities.
Delivering billions of OSD units annually across over 185 markets, our sites in Germany, Ireland, and Italy help provide the optimal balance between product customization and reliable supply at scale.
Every site meets cGMP inspection standards across global regulators, including but not limited to:
Strict containment starts with the right infrastructure.
Isolated and automated dispensing, segregated production areas for highly potent compounds and hormones, and contained packaging operations enable safe handling of compounds with occupational exposure limits (OEL) as low as 0.01 µg/m³.
With high containment suites ready from the outset and a “right-first-time” approach, we help streamline your path to market. Because for the patients who need your therapy, time is life.
Expert content
View all resources
WHITEPAPER
Explore best-practice strategies for highly potent oral solid dose manufacturing
Download the whitepaper
APPLICATION NOTE
Discover how we help make complex OSD manufacturing simple
Download the OSD application note
eBOOK
Get insights into OSD packaging complexity, compliance, and patient centricity
Read the eBook
WHITEPAPER
Learn how to navigate the complexities of modified release formulation and scale-up
Download the whitepaper
Meet our oral solid dose experts
Rossella Bruni
Site Lead, Ascoli
Rossella leads operations at our Ascoli site, drawing on over 23 years at Pfizer across Quality, Operations, and Supply Chain, including roles as Operations Lead and Supply Chain and OPEx Leader.
Ard Lura
Process Manager (PPD), Freiburg
Ard oversees the manufacturing of solid dosage forms for new Pfizer drug products, representing Product and Process Development (PPD) on global teams and leading tech transfer, scale-up, and clinical manufacturing.
Lillian Glennon
PC1 & Business Development Director, Newbridge
Lillian oversees business development and PC1 operations at our Newbridge site in Ireland. She has over 23 years of experience, starting as a quality control specialist and advancing to leadership.
Contact our oral solid dose manufacturing experts to learn how we can help.
Let’s collaborate
We manufacture capsules, pellets, and tablets, supporting both immediate-release and complex modified-release profiles, including prolonged, delayed, and multiphasic release. Our tablet capabilities include:
Fast-dissolve
Bi-layer
Active-coated
Sugar-coated
Dual-active
Overcoated
Laser drilled
Mini
Enteric-coated
Sublingual instant release
Orally disintegrating
Our OSD tech transfer process is built around six core pillars: global reach and understanding, technology, personnel, regulatory compliance, collaboration, and quality.
We start by assessing your product's unique requirements, including formulation complexity, compound classification, and regulatory filings across target markets. The right people are brought into your program at the right time, pairing project management expertise with deep technical knowledge of oral solid dose manufacturing.
Digital tools connect you with our global experts across manufacturing, quality, and regulatory teams, helping ensure real-time visibility. Quality considerations are integrated into every stage, from process validation through to scale-up and continuous improvement, supporting a smooth transition into commercial manufacturing.
Yes. Our oral solid dose manufacturing facilities operate under current Good Manufacturing Practice (cGMP) standards and undergo routine inspections by global regulatory authorities. Inspection experience includes FDA, EMA, PMDA, MHRA, Health Canada, ANVISA, NMPA, TGA, Korean FDA, GCC / GCC-DR, AIFA, COFEPRIS, Turkish MoH, Taiwanese MoH, EAEU, MOITRF, Kazakhstan, and Belarus.
Our regulatory team is well-equipped to support submissions to health authorities worldwide. Download our regulatory support brochure to learn more.
Success
Thank you, your submission has been received!
Latest marketing updates
Let’s stay in touch
Pfizer CentreOne would like to send you information which we believe may be of value to you and relevant to your work. If you would like to receive such information, please tick the box below.
BY TICKING THE BOX AND CLICKING “LET’S COLLABORATE” BELOW, I CONSENT TO RECEIVING THOUGHT LEADERSHIP, INDUSTRY NEWS, AND INVITATIONS BY EMAIL OR OTHER ELECTRONIC MEANS, WHICH PFIZER CENTREONE BELIEVES MAY BE OF VALUE TO ME, RELEVANT TO MY WORK AND TAILORED TO MY PROFESSIONAL PROFILE AND INTERESTS. THIS MAY INCLUDE PROMOTIONAL INFORMATION ON PRODUCTS, SERVICES AND EVENTS PROVIDED OR ORGANIZED BY PFIZER CENTREONE.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Let's Collaborate
A CMO for therapies that define legacies
Follow us
Latest marketing updates
Sign up
© 2025 Pfizer Inc. All rights reserved. Pfizer CentreOne is a registered trademark of Pfizer Inc. Privacy Policy | Terms of Use